SCHEMBL9895488

SCHEMBL9895488

CC(C)(C)OC(=O)N1CCCC2(CN(Cc3cc(F)cnc3Oc3ccc4c(nnn4CC4CC4)c3Br)C2)C1

nearest known ligand 0.34

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 7/20 0.34
CYP3A4 P08684 6/20 0.34
ALDH1A1 P00352 3/20 0.34
RORC P51449 1/20 0.34
TSHR P16473 3/20 0.33
CYP1A2 P05177 2/20 0.33
USP2 O75604 1/20 0.33
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32
SLC6A4 P31645 1/20 0.32
RET P07949 4/20 0.32
GRM2 Q14416 2/20 0.32
CNR2 P34972 1/20 0.32
TLR7 Q9NYK1 1/20 0.31
HDAC1 Q13547 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9897638 0.94 RORC (0.35) CYP2D6CYP3A4ALDH1A1RORCTSHR
SCHEMBL9896603 0.92 GPR119 (0.34) CYP2D6CYP3A4ALDH1A1RORCHTR2A
SCHEMBL9896200 0.87 CYP2D6 (0.41) CYP2D6CYP3A4TSHRCYP1A2GRM2
SCHEMBL9898065 0.86 CYP3A4 (0.38) CYP2D6CYP3A4ALDH1A1TSHRCYP1A2
SCHEMBL9894716 0.85 CYP2D6 (0.39) CYP2D6CYP3A4RORCTSHRCYP1A2
SCHEMBL9895896 0.83 PTGDR2 (0.36) RORCHTR2AHTR2CSLC6A4GRM2
SCHEMBL9895745 0.83 PTGDR2 (0.36) RORCHTR2AHTR2CSLC6A4GRM2
SCHEMBL9896556 0.81 CYP2D6 (0.40) CYP2D6CYP3A4ALDH1A1TSHRCYP1A2
SCHEMBL9895567 0.81 GRM2 (0.36) ALDH1A1GRM2
SCHEMBL9895107 0.81 MEN1 (0.36) CYP2D6CYP3A4TSHRGRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8975286-B2 Ether benzotriazole derivatives MERCK SHARP & DOHME CORP. (US) 2015-03-10 US claimed
US-20120149677-A1 ETHER BENZOTRIAZOLE DERIVATIVES MERCK SHARP & DOHME LLC 2012-06-14 US claimed
US-8975286-B2 Ether benzotriazole derivatives MERCK SHARP & DOHME CORP. (US) 2015-03-10 US disclosed
US-8975286-B2 Ether benzotriazole derivatives MERCK SHARP & DOHME CORP. (US) 2015-03-10 US disclosed
US-8975286-B2 Ether benzotriazole derivatives MERCK SHARP & DOHME CORP. (US) 2015-03-10 US disclosed
US-20120149677-A1 ETHER BENZOTRIAZOLE DERIVATIVES MERCK SHARP & DOHME LLC 2012-06-14 US disclosed
US-20120149677-A1 ETHER BENZOTRIAZOLE DERIVATIVES MERCK SHARP & DOHME LLC 2012-06-14 US disclosed
US-20120149677-A1 ETHER BENZOTRIAZOLE DERIVATIVES MERCK SHARP & DOHME LLC 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149677-A1 ETHER BENZOTRIAZOLE DERIVATIVES GRM2, GRIA2, GRIK2 CYP2D6 2110/4885CYP3A4 2317/4885ALDH1A1 3327/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.